Andrographolide potentiates the antitumor effect of topotecan in acute myeloid leukemia cells through an intrinsic apoptotic pathway

References

• LondonWBFrantzCNCampbellLAPhase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children’s Oncology Group studyJ Clin Oncol201028243808381520660830
   PubMed Web of Science ®Google Scholar
• PerkinsJBGoldsteinSCDawsonJLPhase I study of topotecan, ifosfamide, and etoposide (TIME) with autologous stem cell transplant in refractory cancer: pharmacokinetic and pharmacodynamic correlatesClin Cancer Res201117247743775322028494
   PubMed Web of Science ®Google Scholar
• ZhangFLWangPLiuYHTopoisomerase I inhibitors, shikonin and topotecan, inhibit growth and induce apoptosis of glioma cells and glioma stem cellsPLoS One2013811e8181524303074
   PubMed Web of Science ®Google Scholar
• AljuffaliIAMockJNCostynLJEnhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancerCancer Biol Ther201112540742021709443
   PubMed Web of Science ®Google Scholar
• TsunetohSTeraiYSasakiHTopotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancersCancer Biol Ther201010111137114620935474
   PubMed Web of Science ®Google Scholar
• TsangPSCheukATChenQRSynthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastomaBMC Cancer20121210122436457
   PubMed Web of Science ®Google Scholar
• SrourSABordersEBCherryMAHolterJHermanTSelbyGBRole of topotecan, vinorelbine, thiotepa and gemcitabine chemotherapy in relapsed/refractory adult acute leukemiaLeuk Lymphoma201556102962296425721752
   PubMed Web of Science ®Google Scholar
• ChintagumpalaMMFriedmanHSStewartCFA phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the Children’s Oncology GroupJ Neurooncology2006772193198
   PubMed Web of Science ®Google Scholar
• KlautkeGSchützeMBomborIBeneckeRPiekJFietkauRConcurrent chemoradiotherapy and adjuvant chemotherapy with topotecan for patients with glioblastoma multiformeJ Neurooncology2006772199205
   PubMed Web of Science ®Google Scholar
• KollmannsbergerCMrossKJakobAKanzLBokemeyerCTopotecan – a novel topoisomerase I inhibitor: pharmacology and clinical experienceOncology19995611129885371
   PubMed Web of Science ®Google Scholar
• ChangJZhangRMZhangYAndrographolide drop-pill in treatment of acute upper respiratory tract infection with external wind-heat syndrome: a multicenter and randomized controlled trialZhong Xi Yi Jie He Xue Bao20086121238124519063836
   PubMedGoogle Scholar
• SarafSJainAHurkatPJainSKTopotecan liposomes: a visit from a molecular to a therapeutic platformCrit Rev Ther Drug Carrier Syst201633540143227910741
   PubMed Web of Science ®Google Scholar
• XingJQiXJiangYTopotecan hydrochloride liposomes incorporated into thermosensitive hydrogel for sustained and efficient in situ therapy of H22 tumor in Kunming micePharm Dev Technol2014918
   Google Scholar
• ChernovLDeyellRJAnanthaMDos SantosNGilabert-OriolRBallyMBOptimization of liposomal topotecan for use in treating neuroblastomaCancer Med2017661240125428544814
   PubMed Web of Science ®Google Scholar
• TessonMRaeCNixonCBabichJWMairsRJPreliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugsJ Pharm Pharmacol201668791292127139157
   PubMed Web of Science ®Google Scholar
• KuboTFujiwaraKHottaKA phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102Cancer Chemother Pharmacol201678476977427544764
   PubMed Web of Science ®Google Scholar
• GhoshIMallickIRaySFeasibility and efficacy of salvage radiotherapy with concurrent weekly topotecan in recurrent primitive neuroectodermal tumorIndian J Cancer2015521252626837963
   PubMed Web of Science ®Google Scholar
• SunWWangTShiFRandomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomyBMC Cancer20151535325935645
   PubMed Web of Science ®Google Scholar
• GiovannettiEMeyVDanesiRInteraction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profileBr J Cancer200592468168915700043
   PubMed Web of Science ®Google Scholar
• CarcabosoAMElmeliegyMAShenJTyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomasCancer Res201070114499450820460504
   PubMed Web of Science ®Google Scholar
• KhalifeREl-HayekSTarrasOHodrojMHRizkSAntiproliferative and proapoptotic effects of topotecan in combination with thymoquinone on acute myelogenous leukemiaClin Lymphoma Myeloma Leuk201414SupplS46S5525486955
   PubMedGoogle Scholar
• FrumovitzMMunsellMFBurzawaJKCombination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervixGynecol Oncol20171441465027823771
   PubMed Web of Science ®Google Scholar
• ChaturvediNKMcGuireTRCoulterDWImproved therapy for neuroblastoma using a combination approach: superior efficacy with vismodegib and topotecanOncotarget2016712152151522926934655
   PubMedGoogle Scholar
• PengTHuMWuTTAndrographolide suppresses proliferation of nasopharyngeal carcinoma cells via attenuating NF-κB pathwayBiomed Res Int2015201573505625861643
   PubMed Web of Science ®Google Scholar
• ZhangQQZhouDLDingYAndrographolide inhibits melanoma tumor growth by inactivating the TLR4/NF-κB signaling pathwayMelanoma Res201424654555525244079
   PubMed Web of Science ®Google Scholar
• HossainSUrbiZSuleARahmanHAndrographis paniculata (Burm. f.) wall. ex nees: a review of ethnobotany, phytochemistry, and pharmacologyScientific World J20142014274905
   Google Scholar
• RobatiMHoltzDDuntonCJA review of topotecan in combination chemotherapy for advanced cervical cancerTher Clin Risk Manag20084121321818728710
   PubMedGoogle Scholar
• HormannVKumi-DiakaJDurityMRathinaveluAAnticancer activities of genistein-topotecan combination in prostate cancer cellsJ Cell Mol Med201216112631263622452992
   PubMed Web of Science ®Google Scholar
• AdamsDJSandvoldMLMyhrenFJacobsenTFGilesFRizzieriDAAnti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cellsLeuk Lymphoma200849478679718398748
   PubMed Web of Science ®Google Scholar
• YangTYaoSZhangXGuoYAndrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathwaysDrug Des Devel Ther20161013891397
   PubMed Web of Science ®Google Scholar
• KumarDDasBSenRAndrographolide analogue induces apoptosis and autophagy mediated cell death in U937 cells by inhibition of PI3K/Akt/mTOR pathwayPLoS One20151010e013965726436418
   PubMed Web of Science ®Google Scholar
• WuCCHuangKFYangTYThe topoisomerase 1 inhibitor austrobailignan-1 isolated from koelreuteria henryi induces a G2/M-phase arrest and cell death independently of p53 in non-small cell lung cancer cellsPLoS One2015107e013205226147394
   PubMed Web of Science ®Google Scholar
• MauryaDKAyuzawaRDoiCTroyerDTamuraMTopoisomerase I inhibitor SN-38 effectively attenuates growth of human non-small cell lung cancer cell lines in vitro and in vivoJ Environ Pathol Toxicol Oncol201130111021609311
   PubMed Web of Science ®Google Scholar
• LiJCheungHYZhangZChanGKFongWFAndrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen speciesEur J Pharmacol20075681–3314417512926
   PubMed Web of Science ®Google Scholar
• TomicicMTChristmannMKainaBTopotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavageJ Pharmacol Exp Ther2010332131632519812371
   PubMed Web of Science ®Google Scholar
• SchmidtFRiegerJWischhusenJNaumannUWellerMGlioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damageEur J Pharmacol20014121212511166732
   PubMed Web of Science ®Google Scholar
• PratheeshkumarPSheejaKKuttanGAndrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expressionImmunopharmacol Immunotoxicol201234114315121682651
   PubMed Web of Science ®Google Scholar
• YanJChenYHeCYangZZLuCChenXSAndrographolide induces cell cycle arrest and apoptosis in human rheumatoid arthritis fibroblast-like synoviocytesCell Biol Toxicol2012281475622012578
   PubMed Web of Science ®Google Scholar
• YangSEvensAMPrachandSMitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculataClin Cancer Res201016194755476820798229
   PubMed Web of Science ®Google Scholar
• YunosNMMutalipSSJauriMHYuJQHuqFAnti-proliferative and pro-apoptotic effects from sequenced combinations of andrographolide and cisplatin on ovarian cancer cell linesAnticancer Res201333104365437124123004
   PubMed Web of Science ®Google Scholar
• UckunFMStewartCFReamanGIn vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cellsBlood19958510281728287742543
   PubMed Web of Science ®Google Scholar